Vogozen GM2 Tablets (Metformin HCl (PR), Glimepiride & Voglibose) – Advanced Diabetes Management

Vogozen GM2 Tablets combine Metformin HCl (Prolonged Release), an insulin sensitizer, Glimepiride, a sulfonylurea that stimulates insulin secretion, and Voglibose, an alpha-glucosidase inhibitor that reduces post-meal glucose spikes. This triple-action formula effectively controls Type 2 Diabetes Mellitus and helps maintain optimal blood sugar levels.

Indications & Uses:

  • Type 2 Diabetes Mellitus: Helps regulate blood glucose levels and improve insulin sensitivity.
  • Postprandial Hyperglycemia: Controls sudden sugar spikes after meals by delaying carbohydrate absorption.
  • Insulin Resistance: Enhances insulin utilization and reduces the risk of diabetes complications.

Dosage & Administration:

  • • Take as prescribed by a physician, usually once daily with meals.
  • • Swallow whole; do not crush or chew.
  • • Regular monitoring of blood sugar levels is recommended.

Possible Side Effects:

  • • Common: Nausea, bloating, mild hypoglycemia, dizziness.
  • • Rare (Seek medical help): Severe hypoglycemia, allergic reactions, lactic acidosis (in Metformin users).

Precautions & Warnings:

  • • Not recommended for patients with severe kidney or liver impairment.
  • • Use with caution in pregnant and breastfeeding women.
  • • Regular dietary control and exercise enhance medication efficacy.

Category:

Antidiabetic | Oral Hypoglycemic Agents | Combination Therapy

Brand: Vogozen GM2

Composition:Metformin HCI I.P 500mg,Glimepiride I.P 2mg,Voglibose I.P 0.2mg

Packing: 10*10 blister

Shelf life: 24 months

Company Name:-Zaikon Lifescience opc Pvt.Ltd